» Articles » PMID: 21801423

A Metadata Description of the Data in "A Metabolomic Comparison of Urinary Changes in Type 2 Diabetes in Mouse, Rat, and Human."

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2011 Aug 2
PMID 21801423
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolomics is a rapidly developing functional genomic tool that has a wide range of applications in diverse fields in biology and medicine. However, unlike transcriptomics and proteomics there is currently no central repository for the depositing of data despite efforts by the Metabolomics Standard Initiative (MSI) to develop a standardised description of a metabolomic experiment.

Findings: In this manuscript we describe how the MSI description has been applied to a published dataset involving the identification of cross-species metabolic biomarkers associated with type II diabetes. The study describes sample collection of urine from mice, rats and human volunteers, and the subsequent acquisition of data by high resolution 1H NMR spectroscopy. The metadata is described to demonstrate how the MSI descriptions could be applied in a manuscript and the spectra have also been made available for the mouse and rat studies to allow others to process the data.

Conclusions: The intention of this manuscript is to stimulate discussion as to whether the MSI description is sufficient to describe the metadata associated with metabolomic experiments and encourage others to make their data available to other researchers.

Citing Articles

CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.

Li H, Shi X, Jiang H, Kang J, Yu M, Li Q J Cell Mol Med. 2020; 24(13):7417-7426.

PMID: 32469143 PMC: 7339182. DOI: 10.1111/jcmm.15357.


Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics.

Mamtimin B, Xia G, Mijit M, Hizbulla M, Kurbantay N, You L Pharmacogn Mag. 2015; 11(44):698-706.

PMID: 26600713 PMC: 4621637. DOI: 10.4103/0973-1296.165551.


COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data access.

Salek R, Neumann S, Schober D, Hummel J, Billiau K, Kopka J Metabolomics. 2015; 11(6):1587-1597.

PMID: 26491418 PMC: 4605977. DOI: 10.1007/s11306-015-0810-y.


Metabolonote: a wiki-based database for managing hierarchical metadata of metabolome analyses.

Ara T, Enomoto M, Arita M, Ikeda C, Kera K, Yamada M Front Bioeng Biotechnol. 2015; 3:38.

PMID: 25905099 PMC: 4388006. DOI: 10.3389/fbioe.2015.00038.


Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps.

Bergin I, Witzmann F Int J Biomed Nanosci Nanotechnol. 2013; 3(1-2).

PMID: 24228068 PMC: 3822607. DOI: 10.1504/IJBNN.2013.054515.


References
1.
Coleman D, Hummel K . The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia. 1973; 9(4):287-93. DOI: 10.1007/BF01221856. View

2.
Sansone S, Fan T, Goodacre R, Griffin J, Hardy N, Kaddurah-Daouk R . The metabolomics standards initiative. Nat Biotechnol. 2007; 25(8):846-8. DOI: 10.1038/nbt0807-846b. View

3.
Salek R, Maguire M, Bentley E, Rubtsov D, Hough T, Cheeseman M . A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2006; 29(2):99-108. DOI: 10.1152/physiolgenomics.00194.2006. View

4.
Chen H, Charlat O, Tartaglia L, Woolf E, Weng X, Ellis S . Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996; 84(3):491-5. DOI: 10.1016/s0092-8674(00)81294-5. View

5.
Taylor C, Paton N, Lilley K, Binz P, Julian Jr R, Jones A . The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol. 2007; 25(8):887-93. DOI: 10.1038/nbt1329. View